Revision of Cipla
mediawikibotAB-V1Rendered
Cipla Limited is an Indian multinational pharmaceutical company, headquartered in Mumbai, India. Cipla primarily develops medicines to treat respiratory, cardiovascular disease, arthritis, diabetes, weight control and depression; other medical conditions.As of 17 September 2014, its market capitalisation was ₹49,611.58 crore (equivalent to ₹560 billion or US$7.5 billion in 2020), making it India's 42nd largest publicly traded company by market value.On 23 April 2019, Cipla appointed Dr. from Wikipedia
VIAF: 154074217
Indian multi-national pharmaceutical and biotechnology company
Wikitext diff vs parent
{{DISPLAYTITLE:Cipla}} Cipla Limited is an Indian multinational pharmaceutical company, headquartered in Mumbai, India. Cipla primarily develops medicines to treat respiratory, cardiovascular disease, arthritis, diabetes, weight control and depression; other medical conditions.As of 17 September 2014, its market capitalisation was ₹49,611.58 crore (equivalent to ₹560 billion or US$7.5 billion in 2020), making it India's 42nd largest publicly traded company by market value.On 23 April 2019, Cipla appointed Dr.<small> from [https://en.wikipedia.org/wiki/Cipla Wikipedia]</small>{{SF| {{Twt|cipla_global}} {{Twt|CiplaRSA}} {{Wb|http://www.cipla.com|cipla.com}} {{Fb|Cipla}} }} {{IDF|{{Wd|Q905572}}{{Isni|0000000417668058}} }} {{VIAF|154074217}} {{VHID|20185649151}}{{#subtitle: <big>Indian multi-national pharmaceutical and biotechnology company</big>}}